The latest IDF Diabetes Atlas (2025) reports that diabetes affects 589 million adults (20-79 years) around the world in 2024, with over 4 in 10 unaware that they have the condition.

Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Illumina and Qiagen recently announced a 15-year partnership to develop next-generation sequencing-based in vitro diagnostic kits, including companion diagnostics. The deal accompanied announcements that Qiagen CEO Peer Schatz would step dow

Genomic services provider Novogene has signed an agreement to develop a companion diagnostic for a cancer drug under development at Chipscreen Biosciences, the Chinese companies said today.

Thermo Fisher Scientific on Wednesday reported a 6 percent year-over-year increase in its third quarter revenues, driven by growth across most of its business segments.

Illumina reported after the close of the market on Thursday that its third quarter 2019 revenues grew 6 percent year over year.

Danaher on Thursday reported a 4 percent year-over-year increase in its third quarter revenues, which included a 6 percent rise in life sciences segment revenues and an increase in its diagnostics segment of almost 7 percent.

Qiagen reported after the close of the market on Wednesday that its third quarter revenues increased 1 percent year over year, missing analysts' consensus estimate.

PerkinElmer reported after the close of the market a 5 percent year-over-year increase in revenues for the third quarter, falling short of the consensus Wall Street estimate. For the three months ended Sept. 29, the Waltham, Massachusetts-ba

Edan Diagnostics announced on Sunday it has acquired LGCs Clarilight molecular diagnostics, point-of-care platform for an undisclosed amount. The two firms have also agreed to partner to develop molecular diagnostic assays designed for Clari

Danaher announced Wednesday that its wholly owned subsidiary DH Europe Finance has priced its offering of $3.97 billion senior notes. Proceeds will be used to fund part of the companys planned $21.4 billion acquisition of GE Life Sciences Bi

Akadeum Life Sciences said on Wednesday that it is collaborating with Agilent Technologies to develop a new method of isolating target molecules for analytical workflows. Akadeum is currently developing a method that involves microbubbles to